BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 6, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 9, 2017
View Archived Issues
BridgeBio Pharma outlines novel approach in genetic diseases
Read More
First subject enrolled in phase IIa study of Therapix Biosciences' THX-TS01
Read More
Orion presents Bdr4 inhibitors
Read More
Evoke Pharma offers additional data from phase III study of Gimoti
Read More
Eisai expands development and marketing rights to Belviq
Read More
APT Therapeutics and AstraZeneca enter agreement regarding APT-102
Read More
Cerveau finalizes license agreement with Merck & Co. for tau imaging agent
Read More
Acucela's emixustat hydrochloride granted orphan drug status in U.S. for Stargardt disease
Read More
Genocea Biosciences reports interim results from phase IIb trial of GEN-003
Read More
FDA gives orphan drug designation to PTC Therapeutics' RG-7916 for SMA
Read More
Argenx initiates phase II study of ARGX-113 for myasthenia gravis
Read More
Alexion Pharmaceuticals' ALXN-1210 awarded FDA orphan status for PNH
Read More
Ipsen agrees to acquire global oncology assets from Merrimack Pharmaceuticals
Read More
PaxVax, NIH and DoD form chikungunya vaccine partnership
Read More
FDA conditionally accepts Dsuvia as brand name for AcelRx's ARX-04
Read More
Lilly patents somatostatin sst5 receptor antagonists
Read More
Astex Pharmaceuticals and GSK describe NRF2 regulators
Read More
TGR5 modulators described in Intercept/Servier patent
Read More
Corsair Pharma reports prostacyclin analogues for PAH
Read More
Hanlin Scientific patents agents for cancer and amyloidosis
Read More
Phase III trial of Seciera for dry eye disease meets endpoints
Read More
FDA accepts for review BLA for LFB's eptacog beta for hemophilia
Read More
Aridis Pharmaceuticals' AR-301 shows promising results in phase I/IIa study
Read More
AiCuris begins clinical development of AIC-4998
Read More
CalciMedica commences phase I studies of CM-4620
Read More
FDA grants fast track status to FCX-007 from Fibrocell Science
Read More